$8,000
IN HONORARIUMS
The Cureus Journal of Medical Science is proud to introduce the publishing competition on Clinical Applications and Benefits Using Closed-Incision Negative Pressure Therapy (ciNPT) for Incision and Surrounding Soft Tissue Management.
A closed-incision negative pressure therapy (ciNPT) system is a novel system, including novel foam dressings and a negative pressure therapy unit, which can be used on closed, surgical incisions (closed incisional negative pressure therapy).
To encourage continued research and knowledge sharing focused on recent advances in Closed-Incisional Negative Pressure Therapy (ciNPT), we are seeking the following:
- Case reports and case series that explore and document clinical results of ciNPT using novel dressings
- Original articles analyzing ciNPT using novel dressings on clinical efficacy, length-of-stay, patient comfort and patient compliance
- Technical reports outlining and evaluating procedural experience and practice knowledge using ciNPT technology with novel dressings
To foster educational awareness, our goal is to share the results with the broad surgical community worldwide. To encourage dissemination, all published materials will be Open Access and indexed with PubMed Central. We encourage any surgeon or clinician in the surgical community to contribute!
Program administration has been enabled through the financial support of KCI. Article selection, editorial review, peer review, publication and competition winner determination are strictly independent of the sponsor.
Peer Review Panel
All article submissions will undergo an independent pre-publication peer review conducted by a world-class team of experts.
Christopher Bibbo
DO | OrthopaedicsInternational Center for Limb Lengthening, Rubin Institute for Advanced Orthopaedics, Baltimore, USA
Owen Johnson III
MD | Plastic SurgeryDepartment of Plastic and Reconstructive Surgery, William Beaumont Army Medical Center, El Paso, USA
Patrick C. Murray
MD, MSc, Assistant Professor | OrthopaedicsOrthopedic Surgery, University of Hawaii, Honolulu, USA
Alberto Carli
Assistant Professor, MSc, MD | OrthopaedicsHospital for Special Surgery, New York, USA
Austin M. Cavelli
PA, MSc | OrthopaedicsAdult Reconstruction & Joint Replacement Surgery, Hospital for Special Surgery, New York, USA
Brett Crist
MD | OrthopaedicsDirector, Orthopaedic Trauma Fellowship, University of Missouri Health Care, Columbia, MO, USA
Michael Cross
MD | OrthopaedicsAdult Reconstruction & Joint Replacement Surgery, Hospital for Special Surgery, New York, USA
Anthony N. Dardano
Associate Professor | Plastic SurgeryDepartment of Surgery-Plastic and Reconstructive Surgery, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA
Vikisha Fripp
MD | Plastic SurgeryDepartment of Plastic Surgery, Providence Hospital, Washington D.C., USA
Tripp Holton
MD | Plastic SurgeryMicrovascular Surgery, Anne Arundel Medical Center, Annapolis, USA
Competition Entries
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to score and discuss these articles. Remember, honorariums will be awarded to the three highest-scoring articles!
Requirements
Competition entry and article submission is entirely free. All submitted work must be previously unpublished. Eligible entries include original articles, case reports/series, and technical reports.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting images, charts, tables and/or videos within their article submissions. Reference limits vary by article type. For additional information on publishing with Cureus, please refer to our Author Guide.
Other Stipulations
- All clinical studies must be compliant with applicable regulatory, ethics / IRB, and other rules governing protection of human subjects.
- All non-clinical studies must be compliant with applicable AAUC, AAALAC, and other related regulations.
- This program is not intended to promote or otherwise encourage unapproved, un-cleared use of products or any product for unapproved new use.
- This program in no way promotes or purports to encourage any research that is not in compliance with any local, federal, or other applicable governing laws.
Statement of Independence
Cureus Publishing Competitions are intended to encourage medical discovery and document clinical experiences – be they positive, negative, or neutral and foster broader educational outreach through Open Access publication that is free to both authors and readers.
Article submissions must adhere to the described “call for articles” and are open to any and all related manufacturer or vendor technologies.
As a firewall to ensure objective and credible science, article selection, editorial review, peer review and publication are strictly independent of the sponsoring company.
Winning articles are selected exclusively via peer review panel and community crowdsourced scoring. Neither the sponsoring company, nor Cureus, can determine the competition outcome.
Awards
Winning Article Awards
The three highest Cureus SIQ™ (Scholarly Impact Quotient™) scored published articles will be awarded an honorarium for Cureus Scientific Excellence™:
- $5,000 USD for 1st place
- $2,000 USD for 2nd place
- $1,000 USD for 3rd place
Subsequent to a formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ scores allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community reviews.
Eligible articles must receive a minimum of 5 scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
Sunshine Act Reporting
Section 6002 of the Affordable Care Act requires applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value made to physicians and teaching hospitals. For winning article and referral awards paid to “covered recipients,” award fees shall be supplied to KCI for subsequent Sunshine Act reporting.
Key Dates
- Thursday, January 16, 2020 – Competition begins; articles may now be submitted.
- Tuesday, June 9, 2020 – Article submission deadline @ 5:00 pm PT (deadline extended!)
- Tuesday, July 7, 2020 – Peer review of all eligible articles concludes.
- Tuesday, August 4, 2020 – Crowdsourced scoring (SIQ) complete @ 5:00 pm PT
- Thursday, August 6, 2020 – Winning articles announced